ALK7-targeted siRNA (Brightgene Bio-Medical Technology)

ALK7靶向siRNA（博瑞医药）

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameALK7-targeted siRNA (Brightgene Bio-Medical Technology)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionActivin receptor type-1C inhibitors
TargetsActivin receptor type-1C
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBrightgene Bio-Medical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBrightgene Bio-Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A